+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Regenerative Medicine Market Size and Forecasts 2020-2030: Global and Regional Share, Trends, and Growth Opportunity Analysis by Technology; Application; and End-User

  • PDF Icon

    Report

  • 132 Pages
  • August 2024
  • Region: Global
  • IHR Insights
  • ID: 5995369
UP TO OFF until Dec 31st 2024
10% Free customization
10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

This report offers a comprehensive examination of the regenerative medicine market from 2020 to 2030. This detailed analysis provides insights into market dynamics, including key trends, drivers, challenges, and opportunities shaping the industry. The report covers the competitive landscape, regulatory frameworks, and regional variations, aiming to guide stakeholders such as industry players, investors, and policymakers in making informed decisions and developing strategies for market penetration and growth.

Market Dynamics:

The growth of the regenerative medicine market is driven by several factors, including increasing prevalence of chronic diseases, advancements in biotechnology, and rising investments in research and development. Key trends such as the expansion of clinical applications and the integration of cutting-edge technologies are fueling market growth. However, challenges such as high costs, regulatory hurdles, and ethical concerns continue to impact market dynamics.

Key Market Drivers:

1. Increasing Prevalence of Chronic Diseases: The rising incidence of chronic diseases such as cardiovascular conditions, neurodegenerative disorders, and diabetes drives the demand for regenerative therapies that offer potential for long-term solutions and improved quality of life.

2. Advancements in Biotechnology: Innovations in stem cell research, gene editing technologies (e.g., CRISPR), and tissue engineering are accelerating the development of regenerative medicine products, enhancing their efficacy and applicability.

3. Growing Investments in R&D: Significant investments from government bodies, private companies, and research institutions are advancing the field of regenerative medicine, leading to the development of new therapies and expanding clinical applications.

Key Market Challenges:

1. High Costs of Treatment: The high costs associated with regenerative therapies, including research, development, and manufacturing expenses, pose a significant barrier to widespread adoption, particularly in emerging markets.

2. Regulatory and Ethical Issues: The complex regulatory environment and ethical concerns surrounding regenerative medicine, such as stem cell sourcing and gene editing, present challenges for approval and commercialization.

3. Limited Awareness and Accessibility: Despite advancements, limited awareness among healthcare professionals and patients, coupled with accessibility issues, hinder the adoption of regenerative therapies in some regions.

Market Trends:

1. Integration of Advanced Technologies: The incorporation of technologies such as AI and machine learning in regenerative medicine is enhancing research capabilities, data analysis, and the development of personalized therapies.

2. Rise of Autologous Cell Therapies: There is a growing preference for autologous cell therapies, which use a patient's own cells for treatment, reducing the risk of immune rejection and improving clinical outcomes.

3. Expansion into New Therapeutic Areas: Regenerative medicine is increasingly exploring new therapeutic areas, including age-related diseases and genetic disorders, broadening its application scope and market potential.

Market Size Estimation:

The global regenerative medicine market is projected to reach USD 95 billion by 2030, growing at a CAGR of 11.5% from 2024 to 2030. This growth is driven by increasing clinical applications, advancements in regenerative technologies, and rising healthcare investments. North America is expected to maintain its leading position due to a robust healthcare infrastructure and high R&D investments. Meanwhile, the Asia Pacific region is anticipated to exhibit the highest growth rate, supported by expanding healthcare access and growing research activities.

Market Segmentation:

1. By Technology:

  • Stem Cell Therapy: Involves the use of stem cells to repair or replace damaged tissues and organs.
  • Gene Therapy: Focuses on correcting or replacing defective genes to treat or prevent diseases.
  • Tissue Engineering: Combines cells, biomaterials, and growth factors to create functional tissues and organs.
  • Cellular Therapy: Utilizes various types of cells, including immune cells, to treat diseases and injuries.

2. By Application:

  • Orthopaedics: Regenerative therapies for bone and joint repair, including treatments for fractures and arthritis.
  • Cardiovascular: Therapies for heart disease, including tissue repair and regeneration for cardiac muscle.
  • Neurology: Treatments for neurodegenerative disorders such as Parkinson's and Alzheimer's diseases.
  • Dermatology: Applications in skin regeneration and repair, including wound healing and cosmetic applications.
  • Oncology: Regenerative approaches for cancer treatment and recovery, including targeted therapies and immunotherapies.

3. By End-User:

  • Hospitals and Clinics: Providers of regenerative therapies and treatments in clinical settings.
  • Research Institutions: Institutions conducting research and development in regenerative medicine.
  • Pharmaceutical and Biotechnology Companies: Companies involved in developing and commercializing regenerative therapies.
  • Others: Includes government agencies, non-profit organizations, and specialized research centers.

4. By Region:

  • North America:
  • United States
  • Canada
  • Europe:
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia Pacific:
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
  • Latin America:
  • Brazil
  • Argentina
  • Rest of Latin America
  • Middle East and Africa:
  • GCC
  • South Africa
  • Rest of Middle East and Africa

Recent Developments:

1. Approval of Advanced Gene Therapies: Recent regulatory approvals for innovative gene therapies have opened new avenues for treating genetic disorders, with significant advancements in CRISPR technology and its applications in clinical trials.

2. Breakthroughs in Stem Cell Research: New research findings have demonstrated promising results in stem cell treatments for neurodegenerative diseases and spinal cord injuries, offering hope for future therapies.

3. Expansion of Clinical Trials: Increased investment in regenerative medicine has led to a surge in clinical trials, particularly in the fields of oncology and cardiovascular diseases, enhancing the development pipeline for new therapies.

4. Collaborations and Partnerships: Major pharmaceutical and biotechnology companies are forming strategic partnerships with academic institutions and research organizations to accelerate the development of regenerative therapies and expand market reach.

5. Technological Innovations: Advances in tissue engineering and 3D bioprinting are enabling the creation of complex tissue structures and organ models, advancing the field of regenerative medicine and its applications.

Competitive Landscape:

The regenerative medicine market is characterized by a competitive landscape with key players actively involved in research, development, and commercialization of innovative therapies. Leading companies include:

1. Bluebird Bio, Inc.: A prominent player in gene therapy, focusing on innovative treatments for genetic diseases and cancer.

2. Mesoblast Limited: Known for its stem cell-based therapies targeting orthopedic, cardiovascular, and inflammatory conditions.

3. Cellectis S.A.: Specializes in gene-edited cell therapies for oncology and genetic disorders.

4. Organogenesis Holdings Inc.: Provides tissue-engineered products for wound care and orthopedics.

5. Pluristem Therapeutics Inc.: Focuses on cell therapy products for various medical conditions, including muscle injuries and hematologic disorders.

Market Forecast:

The regenerative medicine market is poised for robust growth, driven by technological advancements, increasing demand for personalized therapies, and expanding clinical applications. The Asia Pacific region is expected to experience the highest growth, fueled by rising healthcare investments and growing awareness of regenerative medicine technologies. However, challenges such as high costs and regulatory complexities may impact market growth, requiring strategic innovations and collaborations to address evolving needs.

Regulatory Framework:

The regulatory landscape for regenerative medicine is complex and varies by region. In the United States, the Food and Drug Administration (FDA) oversees the approval of regenerative therapies, requiring rigorous validation and clinical evidence. In Europe, the European Medicines Agency (EMA) and national regulatory bodies regulate these products, focusing on safety, efficacy, and ethical considerations. Global efforts are underway to harmonize regulatory standards and address challenges related to data privacy and cross-border collaborations.

Customer Landscape:

The regenerative medicine market serves a diverse range of customers, including academic researchers, healthcare providers, pharmaceutical companies, and biotechnology firms. Academic and research institutions are key users of regenerative technologies for research and development. Healthcare providers and hospitals are increasingly adopting regenerative therapies for clinical applications, while pharmaceutical and biotechnology companies focus on developing and commercializing innovative treatments. The market also includes agricultural organizations and government agencies exploring regenerative medicine applications.

Regional Analysis:

The market dynamics vary across regions, with North America leading in revenue and technological innovation. Europe follows with strong research and regulatory support. The Asia Pacific region is anticipated to grow the fastest due to increasing healthcare investments and expanding research activities. Latin America and the Middle East and Africa are also experiencing steady growth, driven by improving healthcare infrastructure and research initiatives.

Industry Outlook:

Strategic partnerships, ongoing research, and technological advancements will be crucial for driving innovation and expanding the regenerative medicine market. Companies that focus on these areas will be better positioned to capitalize on emerging opportunities and address evolving patient needs. Key areas of opportunity include:
  • Development of Novel Therapies: Investing in the development of new regenerative therapies for previously untreated conditions, such as rare genetic disorders and age-related diseases, offers significant growth potential.
  • Advancements in Personalized Medicine: Tailoring regenerative treatments to individual patient profiles through advanced genomics and bioinformatics can enhance treatment efficacy and patient outcomes.
  • Expansion into New Geographies: Increasing access to regenerative medicine in emerging markets, such as those in Asia Pacific and Latin America, can drive market growth and reach underserved populations.
  • Integration with Digital Health Technologies: Combining regenerative medicine with digital health solutions, such as telemedicine and remote monitoring, can improve patient management and therapy outcomes.
  • Collaborations with Technology Companies: Partnerships with technology firms specializing in AI, robotics, and data analytics can enhance research capabilities, streamline clinical trials, and accelerate the development of innovative therapies.
By focusing on these opportunities, companies can navigate the competitive landscape, overcome existing challenges, and contribute to the advancement of regenerative medicine, ultimately benefiting patients and the healthcare industry as a whole.

Table of Contents

1. Executive Summary
2. Market Introduction
2.1. Market Definition
2.2. Market Segmentation
2.3. Research Methodology
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Market Trends
4. Global Regenerative Medicine Market, by Technology
4.1. Stem Cell Therapy
4.2. Gene Therapy
4.3. Tissue Engineering
4.4. Other Technologies
5. Global Regenerative Medicine Market, by Application
5.1. Cardiovascular Diseases
5.2. Orthopedic Disorders
5.3. Neurological Disorders
5.4. Others
6. Global Regenerative Medicine Market, by End-User
6.1. Hospitals and Clinics
6.2. Research Institutions
6.3. Pharmaceutical and Biotechnology Companies
6.4. Others
7. Global Regenerative Medicine Market, by Region
7.1. North America
7.1.1. United States
7.1.2. Canada
7.2. Europe
7.2.1. Germany
7.2.2. United Kingdom
7.2.3. France
7.2.4. Italy
7.2.5. Spain
7.2.6. Rest of Europe
7.3. Asia Pacific
7.3.1. China
7.3.2. Japan
7.3.3. India
7.3.4. South Korea
7.3.5. Australia
7.3.6. Rest of Asia Pacific
7.4. South and Central America
7.4.1. Brazil
7.4.2. Argentina
7.4.3. Rest of South and Central America
7.5. Middle East and Africa
7.5.1. Saudi Arabia
7.5.2. South Africa
7.5.3. Rest of Middle East and Africa
8. Competitive Landscape
8.1. Market Share Analysis
8.2. Company Profiles
8.2.1. Novartis AG
8.2.2. Regeneron Pharmaceuticals, Inc.
8.2.3. Vertex Pharmaceuticals Incorporated
8.2.4. Astellas Pharma Inc.
8.2.5. Bluebird Bio, Inc.
8.2.6. Sangamo Therapeutics, Inc.
8.2.7. Cellectis S.a.
8.2.8. Mesoblast Limited
8.2.9. Pluristem Therapeutics Inc.
8.2.10. Integra LifeSciences Holdings Corporation
8.2.11. Organogenesis Holdings Inc.
8.2.12. Stemcell Technologies Inc.
8.2.13. GeneTx Biotherapeutics
8.2.14. Tigenix
8.2.15. Orgenesis Inc.
8.2.16. Erytech Pharma
8.2.17. Inovio Pharmaceuticals, Inc.
8.2.18. Human Stem Cells Institute
8.2.19. Athersys, Inc.
8.2.20. ReNeuron Group plc
9. Conclusion and Future Outlook10. Appendix
List of Tables
Table 1: Global Regenerative Medicine Market Value by Technology, 2022-2032 (USD Million)
Table 2: Global Regenerative Medicine Market Value by Application, 2022-2032 (USD Million)
Table 3: Global Regenerative Medicine Market Value by End-User, 2022-2032 (USD Million)
Table 4: North America Regenerative Medicine Market Value by Country, 2022-2032 (USD Million)
Table 5: United States Regenerative Medicine Market Value by Technology, 2022-2032 (USD Million)
Table 6: United States Regenerative Medicine Market Value by Application, 2022-2032 (USD Million)
Table 7: United States Regenerative Medicine Market Value by End-User, 2022-2032 (USD Million)
Table 8: Canada Regenerative Medicine Market Value by Technology, 2022-2032 (USD Million)
Table 9: Canada Regenerative Medicine Market Value by Application, 2022-2032 (USD Million)
Table 10: Canada Regenerative Medicine Market Value by End-User, 2022-2032 (USD Million)
Table 11: Mexico Regenerative Medicine Market Value by Technology, 2022-2032 (USD Million)
Table 12: Mexico Regenerative Medicine Market Value by Application, 2022-2032 (USD Million)
Table 13: Mexico Regenerative Medicine Market Value by End-User, 2022-2032 (USD Million)
Table 14: Europe Regenerative Medicine Market Value by Country, 2022-2032 (USD Million)
Table 15: Germany Regenerative Medicine Market Value by Technology, 2022-2032 (USD Million)
Table 16: Germany Regenerative Medicine Market Value by Application, 2022-2032 (USD Million)
Table 17: Germany Regenerative Medicine Market Value by End-User, 2022-2032 (USD Million)
Table 18: United Kingdom Regenerative Medicine Market Value by Technology, 2022-2032 (USD Million)
Table 19: United Kingdom Regenerative Medicine Market Value by Application, 2022-2032 (USD Million)
Table 20: United Kingdom Regenerative Medicine Market Value by End-User, 2022-2032 (USD Million)
Table 21: France Regenerative Medicine Market Value by Technology, 2022-2032 (USD Million)
Table 22: France Regenerative Medicine Market Value by Application, 2022-2032 (USD Million)
Table 23: France Regenerative Medicine Market Value by End-User, 2022-2032 (USD Million)
Table 24: Italy Regenerative Medicine Market Value by Technology, 2022-2032 (USD Million)
Table 25: Italy Regenerative Medicine Market Value by Application, 2022-2032 (USD Million)
Table 26: Italy Regenerative Medicine Market Value by End-User, 2022-2032 (USD Million)
Table 27: Spain Regenerative Medicine Market Value by Technology, 2022-2032 (USD Million)
Table 28: Spain Regenerative Medicine Market Value by Application, 2022-2032 (USD Million)
Table 29: Spain Regenerative Medicine Market Value by End-User, 2022-2032 (USD Million)
Table 30: Russia Regenerative Medicine Market Value by Technology, 2022-2032 (USD Million)
Table 31: Russia Regenerative Medicine Market Value by Application, 2022-2032 (USD Million)
Table 32: Russia Regenerative Medicine Market Value by End-User, 2022-2032 (USD Million)
Table 33: Rest of Europe Regenerative Medicine Market Value by Technology, 2022-2032 (USD Million)
Table 34: Rest of Europe Regenerative Medicine Market Value by Application, 2022-2032 (USD Million)
Table 35: Rest of Europe Regenerative Medicine Market Value by End-User, 2022-2032 (USD Million)
Table 36: Asia Pacific Regenerative Medicine Market Value by Country, 2022-2032 (USD Million)
Table 37: China Regenerative Medicine Market Value by Technology, 2022-2032 (USD Million)
Table 38: China Regenerative Medicine Market Value by Application, 2022-2032 (USD Million)
Table 39: China Regenerative Medicine Market Value by End-User, 2022-2032 (USD Million)
Table 40: Japan Regenerative Medicine Market Value by Technology, 2022-2032 (USD Million)
Table 41: Japan Regenerative Medicine Market Value by Application, 2022-2032 (USD Million)
Table 42: Japan Regenerative Medicine Market Value by End-User, 2022-2032 (USD Million)
Table 43: India Regenerative Medicine Market Value by Technology, 2022-2032 (USD Million)
Table 44: India Regenerative Medicine Market Value by Application, 2022-2032 (USD Million)
Table 45: India Regenerative Medicine Market Value by End-User, 2022-2032 (USD Million)
Table 46: Australia Regenerative Medicine Market Value by Technology, 2022-2032 (USD Million)
Table 47: Australia Regenerative Medicine Market Value by Application, 2022-2032 (USD Million)
Table 48: Australia Regenerative Medicine Market Value by End-User, 2022-2032 (USD Million)
Table 49: South Korea Regenerative Medicine Market Value by Technology, 2022-2032 (USD Million)
Table 50: South Korea Regenerative Medicine Market Value by Application, 2022-2032 (USD Million)
Table 51: South Korea Regenerative Medicine Market Value by End-User, 2022-2032 (USD Million)
Table 52: ASEAN Regenerative Medicine Market Value by Technology, 2022-2032 (USD Million)
Table 53: ASEAN Regenerative Medicine Market Value by Application, 2022-2032 (USD Million)
Table 54: ASEAN Regenerative Medicine Market Value by End-User, 2022-2032 (USD Million)
Table 55: Rest of Asia-Pacific Regenerative Medicine Market Value by Technology, 2022-2032 (USD Million)
Table 56: Rest of Asia-Pacific Regenerative Medicine Market Value by Application, 2022-2032 (USD Million)
Table 57: Rest of Asia-Pacific Regenerative Medicine Market Value by End-User, 2022-2032 (USD Million)
Table 58: MEA Regenerative Medicine Market Value by Country, 2022-2032 (USD Million)
Table 59: Turkey Regenerative Medicine Market Value by Technology, 2022-2032 (USD Million)
Table 60: Turkey Regenerative Medicine Market Value by Application, 2022-2032 (USD Million)
Table 61: Turkey Regenerative Medicine Market Value by End-User, 2022-2032 (USD Million)
Table 62: Saudi Arabia Regenerative Medicine Market Value by Technology, 2022-2032 (USD Million)
Table 63: Saudi Arabia Regenerative Medicine Market Value by Application, 2022-2032 (USD Million)
Table 64: Saudi Arabia Regenerative Medicine Market Value by End-User, 2022-2032 (USD Million)
Table 65: UAE Regenerative Medicine Market Value by Technology, 2022-2032 (USD Million)
Table 66: UAE Regenerative Medicine Market Value by Application, 2022-2032 (USD Million)
Table 67: UAE Regenerative Medicine Market Value by End-User, 2022-2032 (USD Million)
Table 68: South Africa Regenerative Medicine Market Value by Technology, 2022-2032 (USD Million)
Table 69: South Africa Regenerative Medicine Market Value by Application, 2022-2032 (USD Million)
Table 70: South Africa Regenerative Medicine Market Value by End-User, 2022-2032 (USD Million)
Table 71: Rest of MEA Regenerative Medicine Market Value by Technology, 2022-2032 (USD Million)
Table 72: Rest of MEA Regenerative Medicine Market Value by Application, 2022-2032 (USD Million)
Table 73: Rest of MEA Regenerative Medicine Market Value by End-User, 2022-2032 (USD Million)
Table 74: South America Regenerative Medicine Market Value by Country, 2022-2032 (USD Million)
Table 75: Brazil Regenerative Medicine Market Value by Technology, 2022-2032 (USD Million)
Table 76: Brazil Regenerative Medicine Market Value by Application, 2022-2032 (USD Million)
Table 77: Brazil Regenerative Medicine Market Value by End-User, 2022-2032 (USD Million)
Table 78: Argentina Regenerative Medicine Market Value by Technology, 2022-2032 (USD Million)
Table 79: Argentina Regenerative Medicine Market Value by Application, 2022-2032 (USD Million)
Table 80: Argentina Regenerative Medicine Market Value by End-User, 2022-2032 (USD Million)
Table 81: Rest of South America Regenerative Medicine Market Value by Technology, 2022-2032 (USD Million)
Table 82: Rest of South America Regenerative Medicine Market Value by Application, 2022-2032 (USD Million)
Table 83: Rest of South America Regenerative Medicine Market Value by End-User, 2022-2032 (USD Million)
Table 84: Company Regional Footprint
Table 85: Company Industry Footprint
List of Figures
Figure 1: Global Regenerative Medicine Market Segments
Figure 2: Research Timelines
Figure 3: Data Triangulation Method
Figure 4: Market Research Flow
Figure 5: Data Sources
Figure 6: Executive Summary
Figure 7: Global Regenerative Medicine Market Estimates and Forecast (USD Million), 2022-2031
Figure 8: Global Regenerative Medicine Market Absolute Market Opportunity
Figure 9: Global Regenerative Medicine Market Attractiveness Analysis, by Region
Figure 10: Global Regenerative Medicine Market Attractiveness Analysis, by Technology
Figure 11: Global Regenerative Medicine Market Attractiveness Analysis, by Application
Figure 12: Global Regenerative Medicine Market Attractiveness Analysis, by End-User
Figure 13: Global Regenerative Medicine Market Geographical Analysis, 2024-2031
Figure 14: Global Regenerative Medicine Market, by Technology (USD Million)
Figure 15: Global Regenerative Medicine Market, by Application (USD Million)
Figure 16: Global Regenerative Medicine Market, by End-User (USD Million)
Figure 17: Future Market Opportunities
Figure 18: Global Regenerative Medicine Market Outlook
Figure 19: Porter's Five Forces Analysis
Figure 20: Global Regenerative Medicine Market, by Technology
Figure 21: Global Regenerative Medicine Market Basis Point Share (BPS) Analysis, by Technology
Figure 22: Global Regenerative Medicine Market, by Application
Figure 23: Global Regenerative Medicine Market Basis Point Share (BPS) Analysis, by Application
Figure 24: Global Regenerative Medicine Market, by End-User
Figure 25: Global Regenerative Medicine Market Basis Point Share (BPS) Analysis, by End-User
Figure 26: Global Regenerative Medicine Market, by Geography, 2022-2031 (USD Million)
Figure 27: North America Market Snapshot
Figure 28: U.S. Market Snapshot
Figure 29: Canada Market Snapshot
Figure 30: Mexico Market Snapshot
Figure 31: Europe Market Snapshot
Figure 32: Germany Market Snapshot
Figure 33: UK Market Snapshot
Figure 34: France Market Snapshot
Figure 35: Italy Market Snapshot
Figure 36: Russia Market Snapshot
Figure 37: Spain Market Snapshot
Figure 38: Rest of Europe Market Snapshot
Figure 39: Asia-Pacific Market Snapshot
Figure 40: China Market Snapshot
Figure 41: India Market Snapshot
Figure 42: Japan Market Snapshot
Figure 43: Australia Market Snapshot
Figure 44: South Korea Market Snapshot
Figure 45: ASEAN Market Snapshot
Figure 46: Rest of Asia-Pacific Market Snapshot
Figure 47: MEA Market Snapshot
Figure 48: Turkey Market Snapshot
Figure 49: UAE Market Snapshot
Figure 50: Saudi Arabia Market Snapshot
Figure 51: South Africa Market Snapshot
Figure 52: Rest of MEA Market Snapshot
Figure 53: South America Market Snapshot
Figure 54: Brazil Market Snapshot
Figure 55: Argentina Market Snapshot
Figure 56: Rest of South America Market Snapshot
Figure 57: Company Market Ranking Analysis
Figure 58: Ace Matrix
Figure 59: Novartis AG - Company Insights
Figure 60: Novartis AG - Segment Breakdown
Figure 61: Novartis AG - SWOT Analysis
Figure 62: Regeneron Pharmaceuticals, Inc. - Company Insights
Figure 63: Regeneron Pharmaceuticals, Inc. - Segment Breakdown
Figure 64: Regeneron Pharmaceuticals, Inc. - SWOT Analysis
Figure 65: Vertex Pharmaceuticals Incorporated - Company Insights
Figure 66: Vertex Pharmaceuticals Incorporated - Segment Breakdown
Figure 67: Vertex Pharmaceuticals Incorporated - SWOT Analysis
Figure 68: Astellas Pharma Inc. - Company Insights
Figure 69: Astellas Pharma Inc. - Segment Breakdown
Figure 70: Astellas Pharma Inc. - SWOT Analysis
Figure 71: Bluebird Bio, Inc. - Company Insights
Figure 72: Bluebird Bio, Inc. - Segment Breakdown
Figure 73: Bluebird Bio, Inc. - SWOT Analysis
Figure 74: Sangamo Therapeutics, Inc. - Company Insights
Figure 75: Sangamo Therapeutics, Inc. - Segment Breakdown
Figure 76: Sangamo Therapeutics, Inc. - SWOT Analysis
Figure 77: Cellectis S.a. - Company Insights
Figure 78: Cellectis S.a. - Segment Breakdown
Figure 79: Cellectis S.a. - SWOT Analysis
Figure 80: Mesoblast Limited - Company Insights
Figure 81: Mesoblast Limited - Segment Breakdown
Figure 82: Mesoblast Limited - SWOT Analysis
Figure 83: Pluristem Therapeutics Inc. - Company Insights
Figure 84: Pluristem Therapeutics Inc. - Segment Breakdown
Figure 85: Pluristem Therapeutics Inc. - SWOT Analysis
Figure 86: Integra LifeSciences Holdings Corporation - Company Insights
Figure 87: Integra LifeSciences Holdings Corporation - Segment Breakdown
Figure 88: Integra LifeSciences Holdings Corporation - SWOT Analysis
Figure 89: Organogenesis Holdings Inc. - Company Insights
Figure 90: Organogenesis Holdings Inc. - Segment Breakdown
Figure 91: Organogenesis Holdings Inc. - SWOT Analysis
Figure 92: Stemcell Technologies Inc. - Company Insights
Figure 93: Stemcell Technologies Inc. - Segment Breakdown
Figure 94: Stemcell Technologies Inc. - SWOT Analysis
Figure 95: GeneTx Biotherapeutics - Company Insights
Figure 96: GeneTx Biotherapeutics - Segment Breakdown
Figure 97: GeneTx Biotherapeutics - SWOT Analysis
Figure 98: Tigenix - Company Insights
Figure 99: Tigenix - Segment Breakdown
Figure 100: Tigenix - SWOT Analysis
Figure 101: Orgenesis Inc. - Company Insights
Figure 102: Orgenesis Inc. - Segment Breakdown
Figure 103: Orgenesis Inc. - SWOT Analysis
Figure 104: Erytech Pharma - Company Insights
Figure 105: Erytech Pharma - Segment Breakdown
Figure 106: Erytech Pharma - SWOT Analysis
Figure 107: Inovio Pharmaceuticals, Inc. - Company Insights
Figure 108: Inovio Pharmaceuticals, Inc. - Segment Breakdown
Figure 109: Inovio Pharmaceuticals, Inc. - SWOT Analysis
Figure 110: Human Stem Cells Institute - Company Insights
Figure 111: Human Stem Cells Institute - Segment Breakdown
Figure 112: Human Stem Cells Institute - SWOT Analysis
Figure 113: Athersys, Inc. - Company Insights
Figure 114: Athersys, Inc. - Segment Breakdown
Figure 115: Athersys, Inc. - SWOT Analysis
Figure 116: ReNeuron Group plc - Company Insights
Figure 117: ReNeuron Group plc - Segment Breakdown
Figure 118: ReNeuron Group plc - SWOT Analysis

Companies Mentioned

  • Novartis AG
  • Regeneron Pharmaceuticals Inc.
  • Vertex Pharmaceuticals Incorporated
  • Astellas Pharma Inc.
  • Bluebird Bio Inc.
  • Sangamo Therapeutics Inc.
  • Cellectis S.A.
  • Mesoblast Limited
  • Pluristem Therapeutics Inc.
  • Integra LifeSciences Holdings Corporation
  • Organogenesis Holdings Inc.
  • Stemcell Technologies Inc.
  • GeneTx Biotherapeutics
  • Tigenix
  • Orgenesis Inc.
  • Erytech Pharma
  • Inovio Pharmaceuticals Inc.
  • Human Stem Cells Institute
  • Athersys Inc.
  • ReNeuron Group plc